Ironwood Pharma (IRWD) Tops Q2 EPS by 12c, Updates Guidance

Ironwood Pharma (NASDAQ: IRWD) reported Q2 EPS of $0.34, $0.12 better than the analyst estimate of $0.22. Revenue for the quarter came in at $104.1 million versus the consensus estimate of $93.1 million.

GUIDANCE:

Ironwood Pharma sees FY2021 revenue of $390-410 million, versus the consensus of $392 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49